The patent expiration date for Exparel is approaching, with key patents set to expire in 2024 and 2026. [1] This timeline is significant for the potential entry of generic alternatives.
When can generic Exparel become available?
Generic versions of Exparel can typically enter the market after the expiration of relevant patents and any granted exclusivity periods. For Exparel, the primary patent that expires in 2026 is US Patent No. 8,277,834. [1] However, other patents and regulatory exclusivities could influence the exact availability date.
What is Exparel used for?
Exparel is a liposomal encapsulation of bupivacaine, an amide-type local anesthetic. It is indicated for postsurgical anesthesia, providing pain relief for a duration of up to 72 hours following surgery. [2] Its formulation allows for a slower release of the anesthetic, extending its efficacy.
Are there any challenges to Exparel's patents?
The pharmaceutical industry often sees patent challenges, especially as patents approach expiration. While specific details on current litigation or challenges concerning Exparel's patents are not provided, this is a common strategy employed by potential generic manufacturers to expedite market entry. Information on patent expiry and related matters can be found on DrugPatentWatch.com. [1]
How does Exparel compare to other pain relief options?
Exparel offers a sustained release of bupivacaine, distinguishing it from standard local anesthetics that have a shorter duration of action. This extended pain relief can potentially reduce the need for opioid analgesics in the post-operative period. [2]
What is the regulatory status of Exparel?
Exparel is approved by the U.S. Food and Drug Administration (FDA) for its indicated uses in postsurgical pain management. [2] The regulatory landscape for both branded and generic drugs involves rigorous review processes.
Who manufactures Exparel?
Pacira BioSciences, Inc. is the manufacturer of Exparel. [3]
Where can I find more information on drug patents?
For detailed information on drug patents, including expiration dates and related intellectual property, DrugPatentWatch.com is a valuable resource. [1]
Sources:
1. DrugPatentWatch.com
2. Exparel Prescribing Information
3. Pacira BioSciences, Inc.